about
New molecular insights into peripheral T cell lymphomasPrognostic markers in peripheral T-cell lymphomaOverview of alemtuzumab therapy for the treatment of T-cell lymphomas.The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell NeoplasmsVariable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapyEvolving Therapy of Peripheral T-cell Lymphoma: 2010 and beyond.Alemtuzumab in the treatment of chronic lymphocytic lymphoma.CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.New targets of therapy in T-cell lymphomas.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Targeted molecular therapy in peripheral T-cell lymphomas.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Novel treatment avenues for peripheral T-cell lymphomas.From empiric to mechanism-based therapy for peripheral T cell lymphoma.Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group.Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.Successful management of invasive pulmonary nocardiosis and aspergillosis in a patient with T-cell lymphoma: a case report.Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified.CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies.Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.
P2860
Q27026081-702FFD31-519E-4816-95AC-3879C0CA743BQ34166857-244F885E-5A6A-43D4-8D12-D407F86A5C11Q34222228-516101AB-82CF-4AF5-9018-AC89FFA53AB4Q35163220-1ECF24BD-7486-4231-B079-15BE29ECC922Q36365590-FD48F863-9111-44A0-9472-CFB7C8D6FCA2Q36612584-3B9F93F7-6139-4288-9D6F-8F104554EE01Q37134417-50CE21F8-FD80-4ABC-AAA5-B2EA9DE44D2DQ37214534-E146D18C-D83F-4F7B-B598-E138DBA1BDF2Q37255632-04226E73-F4A7-4557-A234-34DA1C5CFFC3Q37701472-47593985-4B48-4154-8CCC-73E374545B8FQ37863688-B502A0E0-4025-4A47-8CEB-CAFAA53B7A69Q37937044-BF7A453D-8FF7-4610-82A7-643088205DD3Q37981969-6A5963C2-D928-4F6D-8080-9D4691874817Q38045460-67A13DCE-2716-4CA4-B33B-ABF746C76D1CQ38186617-CF5D80E7-AFA9-4149-9AAD-0E126F776616Q38466180-9E6F9D27-F59B-4BB2-883E-DEBA0100804FQ40338112-ADA0EF7B-9557-44CC-A210-FFC57EBFC8EFQ42965419-DDA542D4-E830-48C6-BB80-C41B13E17BDEQ43103123-6EF2C94F-02DC-4381-A549-F0B621E865CEQ47697902-B82BF65E-7ECA-49A3-A19F-AC5F89B18C30Q53304621-D2C381B0-08F1-463E-9EE2-AF1DC812C169
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Expression of CD52 in peripheral T-cell lymphoma
@ast
Expression of CD52 in peripheral T-cell lymphoma
@en
Expression of CD52 in peripheral T-cell lymphoma
@nl
type
label
Expression of CD52 in peripheral T-cell lymphoma
@ast
Expression of CD52 in peripheral T-cell lymphoma
@en
Expression of CD52 in peripheral T-cell lymphoma
@nl
prefLabel
Expression of CD52 in peripheral T-cell lymphoma
@ast
Expression of CD52 in peripheral T-cell lymphoma
@en
Expression of CD52 in peripheral T-cell lymphoma
@nl
P2093
P356
P1433
P1476
Expression of CD52 in peripheral T-cell lymphoma
@en
P2093
Pier Paolo Piccaluga
Simona Righi
Stefano A Pileri
P304
P356
10.3324/HAEMATOL.10767
P407
P577
2007-04-01T00:00:00Z